Nkarta, Inc. Stock Issued During Period, Shares, New Issues
Nkarta, Inc. (NKTX) had Stock Issued During Period, Shares, New Issues of 21.01 million shares as of 2024-03-27, per its 10-Q filed 2024-05-09.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-05-09
- 2024-03-27: Stock Issued During Period, Shares, New Issues 21.01M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2024-03-27 | 21.01M shares 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |